Low dose cytarabine in patients with relapsed or refractory Ewing sarcoma
- PMID: 19441111
- DOI: 10.1002/pbc.21940
Low dose cytarabine in patients with relapsed or refractory Ewing sarcoma
Comment on
-
Phase II study of intermediate-dose cytarabine in patients with relapsed or refractory Ewing sarcoma: a report from the Children's Oncology Group.Pediatr Blood Cancer. 2009 Mar;52(3):324-7. doi: 10.1002/pbc.21822. Pediatr Blood Cancer. 2009. PMID: 18989890 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
